Aging
Navigate
Back to articleFigure 6(6 of 6)
100%
Figure 6
Figure 6.Graphical abstract showing that the oncogenic activity of SSH1 is mediated by circadian rhythm disruption and Wnt/β-catenin signaling activation, and that SHH1 is molecular and pharmacological target in patients with HCC.